Van Eck Associates Corp Corcept Therapeutics Inc Transaction History
Van Eck Associates Corp
- $77.4 Billion
- Q1 2025
A detailed history of Van Eck Associates Corp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 109,719 shares of CORT stock, worth $7.74 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
109,719
Previous 88,966
23.33%
Holding current value
$7.74 Million
Previous $4.48 Million
179.54%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
477Shares Held
84MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.17 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$704 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$546 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$434 Million1.13% of portfolio
-
Parallel Advisors, LLC3.97MShares$280 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.56B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...